Prospective randomized clinical trial evaluating the impact of vinegar on lipids in non-diabetics
Notes for this study:
|Values||Change from baseline. mg/L. Mean + 95% CI. Apple cider vinegar: 0.15 [−0.27, 0.57] Placebo: −0.50 [−0.94, −0.05]. Placebo is statistically significantly lower compared with baseline. Apple cider vinegar nonsignificant.|
|Trial Design||Randomized trial|
|Number of Subjects||114|
|Body Types||Obese, Overweight, Average|
In a randomized, double-blind, placebo-controlled trial, 114 non-diabetic participants were assigned to 30 ml of apple cider vinegar or placebo daily for 8 weeks.
The primary outcome was HDL-C, and the apple cider vinegar group say a small increase while the placebo group saw a small decrease. Neither change was statistically significant compared with baseline. There were no other statistically significant effects besides a reduction in HS-CRP in the placebo group.